Ionis Pharmaceuticals | IONS - Interest Income


Ionis Pharmaceuticals reported $-0.66 in Interest Income for its fiscal quarter ending in December of 2024.





Interest Income Change Date
Agios Pharmaceuticals USD 12.41M 959K Dec/2025
Alnylam Pharmaceuticals USD 26.63M 2.05M Dec/2025
Arrowhead Research USD 9.69M 637K Dec/2025
Astellas Pharma JPY 4.12B 2.94B Mar/2024
BioCryst Pharmaceuticals USD -0.13 3.59M Dec/2024
BioMarin Pharmaceutical USD 22.56M 3.35M Mar/2026
Celltrion KRW 621.35M 55.31M Dec/2025
Esperion Therapeutics USD -0.15 0.18 Sep/2024
Exelixis USD 16.13M 1.3M Mar/2026
Ionis Pharmaceuticals USD -0.66 0.29 Dec/2024
Kangmei Pharma CNY 2.44M 635.78K Mar/2026
Knight Therapeutics CAD 2.46M 498K Sep/2024
Laboratorios Farma EUR 139K 42K Jun/2025
Medical Developments International AUD 174K 31K Dec/2024
Moderna USD 70M 3M Dec/2025
Nektar Therapeutics USD -0.18 0.07 Sep/2024
OPKO Health USD 3.02M 264K Sep/2025
Pfizer USD 115M 51M Mar/2026
Pharma Mar EUR 1.63M 3.17M Dec/2025
Qiagen NV USD 20M 4.93M Dec/2025
Regeneron Pharmaceuticals USD 193.3M 18.2M Dec/2025
Sarepta Therapeutics USD 8.74M 359K Dec/2025
Sartorius EUR -31.8M 86.7M Dec/2025
Tilray USD 12.83M 20.19M May/2024
Ultragenyx Pharmaceutical USD 6.51M 649K Dec/2025
Vertex Pharmaceuticals USD 114.8M 7.1M Mar/2026
Zhangzhou Pientzehuang Pharmaceutical CNY 2.73M 3.92M Mar/2026